Immune Biosolutions inc.: federal grants and contributions: 12 agreements; $15.5M value; 3 departments; 6 programs.
Assay record ASY-CA-1S2R5EK139 · Cite as: Assay Systems, “Immune Biosolutions inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/immune-biosolutions-inc/
Immune Biosolutions inc. will develop a medical counter measure (MCM) and contribute to Canada's ability to secure an effective therapeutic in response to COVID-19.
The main objective of the project is to develop at least one bispecific or multispecific therapeutic antibody in pulmonary immuno-oncology. To this end, the company will improve its platform to accelerate the therapeutic antibody discovery process through the implementation of new technologies, automation and high throughput processing of the experimental data collected. This platform will be able to efficiently generate multispecific antibodies with demonstrated therapeutic efficacy.
Working Capital: In the context of the crisis caused by the COVID-19 pandemic, the project aims to ensure the continuity of operations of a company that specializes in the discovery and engineering of humanized chicken antibodies for the pharmaceutical and biotechnology markets.
Immune Biosolutions wishes to expedite the process of discovery of new therapeutic antibodies from chicken, from 8 months to 100 days, to address dire human health needs.
Belated reporting of a grant or contribution; Monies allocated over more than one fiscal year;Repayable Contribution
Monies allocated over more than one fiscal year;Repayable Contribution
The project aims to characterize and evaluate the therapeutic efficacy of bispecific antibodies targeting checkpoint inhibitors of the LILRB family as monotherapy.
Immune Biosolutions wishes to increase its network of potential partners in Japan and sign partnership agreements for the discovery of new innovative medicines with world leaders in the biopharmaceutical sector.
This International Co-Innovation Action Program (ICAP) project will prepare the firm to enter into future international co-innovation work.
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
All grants from Innovation, Science and Economic Development Canada
All grants from Canada Economic Development for Quebec Regions
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.